CONTENTS
ACKNOWLEDGEMENTS...................................................................................................I
1 INTRODUCTION...............................................................................................................................................1
Aim...........................................................................................................................................................................2
Cost-Effectiveness Analysis (CEA)..................................................................................................................2
Coronary Heart Disease (CHD).........................................................................................................................3
TheSWSAHS..........................................................................................................................................................4
Risk Factors..........................................................................................................................................................4
Risk Factors Used in this Analysis...................................................................................................................5
2 PREVIOUS CEAS ON NUTRITION INTERVENTIONS.............................................................................6
Weinstein and Stason (1985)...............................................................................................................................6
Kritiansen, Eggen and Thelle (1991)................................................................................................................8
Crowley, Dunt and Day (1995)..........................................................................................................................9
Hall et al (1988).................................................................................................................................................11
The Interventions in More Detail...................................................................................................................16
Some Key Issues for Each Intervention.................................................................................... 19
3 THE INTERVENTIONS.................................................................................................14
Theinterventiongroups..........................................................................................14
THE INTERVENTIONS IN MORE DETAILS...........................................................................16
4 COST-EFFECTIVENESS ANALYSIS...........................................................................................................21
Effectiveness......................................................................................................................................................21
Cost-effectiveness.............................................................................................................................................29
Sensitivity Analysis - Length of effectiveness...........................................................................................30
Sensitivity Analysis - Take-up rates of programs......................................................................................31
TAKE-UP RATE AMONGST GPS)...............................................................................................................................33
Summary of results...........................................................................................................................................33
5 DISCUSSION...................................................................................................................................................34
Healthy Public Policy......................................................................................................................................34
Building Partnerships.......................................................................................................................................35
Effectiveness and evidence: biomedical, clinical & social behaviour considerations.......................35
Behaviour modification....................................................................................................................................38
Portfolio Investment........................................................................................................................................40
Otherdiseases....................................................................................................................................................41
Equity...................................................................................................................................................................41
REFERENCES.....................................................................................................................................................43
Appendixa.......................................................................................................................................................54
Appendixb.......................................................................................................................................................55
Appendixc.......................................................................................................................................................65
More intriguing information
1. Synchronisation and Differentiation: Two Stages of Coordinative Structure2. Placenta ingestion by rats enhances y- and n-opioid antinociception, but suppresses A-opioid antinociception
3. Initial Public Offerings and Venture Capital in Germany
4. Making International Human Rights Protection More Effective: A Rational-Choice Approach to the Effectiveness of Ius Standi Provisions
5. The name is absent
6. THE UNCERTAIN FUTURE OF THE MEXICAN MARKET FOR U.S. COTTON: IMPACT OF THE ELIMINATION OF TEXTILE AND CLOTHING QUOTAS
7. The name is absent
8. SOME ISSUES CONCERNING SPECIFICATION AND INTERPRETATION OF OUTDOOR RECREATION DEMAND MODELS
9. Moi individuel et moi cosmique Dans la pensee de Romain Rolland
10. Visual Perception of Humanoid Movement